News

istockphoto10d
Diagram Of Plant And Animal Cells Stock Illustration - Download Image Now - Biological Cell, Cell Membrane, Human Cell - iStock
Diagram of generic plant and animal cells, showing major organelles including nucleus, nucleolus, rough endoplasmic reticulum, smooth endoplasmic reticulum, cell membranes, golgi apparatus, ...
BioSpace24d
Mythic Therapeutics Presents Compelling Efficacy Data from its Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Novel cMET- ADC, MYTX-011, in Non-Small Cell Lung ...
WALTHAM, Mass.--(BUSINESS WIRE)--Mythic Therapeutics, a clinical-stage biotechnology company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of ...
Morningstar26d
Mythic Therapeutics Presents Compelling Efficacy Data from its Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Novel cMET- ADC, MYTX-011, in Non-Small Cell Lung ...
Mythic Therapeutics Presents Compelling Efficacy Data from its Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Novel cMET- ADC, MYTX-011, in Non-Small Cell Lung Cancer at the ...
IEEE27d
A Framework for Process-to-Module Modeling of a-Si/c-Si (HIT) Heterojunction Solar Cells to Investigate the Cell-to-Module Efficiency Gap - IEEE Xplore
The cell-to-module efficiency gap observed in a-Si/c-Si heterojunction solar cells is a key challenge to the broad adoption of this technology. To systematically address this issue, we describe an end ...
ascopubs.org29d
Efficacy and safety of MHB088C, a novel B7-H3-targeted ADC, in patients with relapsed extensive-stage small cell lung cancer (ES-SCLC): Subgroup analysis ... - ASCO Publications
8510Background: MHB088C is a novel B7-H3-targeted antibody-drug conjugate (ADC) containing the potent SuperTopoi payload that is 5 to 10 times more potent than Dxd. ... in patients with relapsed ...
ascopubs.org29d
Phase I study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic small cell ... - ASCO Publications
3002Background: iza-bren is a first-in-class ADC comprised of an EGFR x HER3 bispecific antibody conjugated to a novel topo-I inhibitor payload (Ed-04) ... -B01D1), an EGFR x HER3 bispecific ...